lorazepam therapy
The Homeopathic Preparation Nervoheel N can Offer an Alternative . Oct 25, 2007 . The Homeopathic Preparation Nervoheel N can Offer an Alternative to Lorazepam Therapy for Mild Nervous Disorders .
High-dose lorazepam therapy for status epilepticus in a pediatric . High-dose lorazepam therapy for status epilepticus in a pediatric patient. HM Reincke, RL Gilmore, and RJ Kuhn. This report details the management of status .
Orofacial dyskinesias associated with lorazepam therapy. Orofacial dyskinesias associated with lorazepam therapy. Sandyk R. Publication Types:. Case Reports. Mesh Terms:. Anxiety Disorders/drug therapy .
Topiramate Effect in Catatonia: A Case Series -- McDaniel et al . High dose lorazepam therapy, up to 12 mg daily, made no difference in her mute immobility, nor did the addition of divalproex up to 1500 mg daily (valproate .
Parkinsn's List Drug DataBase lorazepam / Ativan ADVERSE REACTIONS: Most of the CNS-related adverse effects associated with lorazepam therapy are dose-dependent. These include headache, drowsiness, ataxia, .
Lorazepam In patients for whom prolonged lorazepam therapy is indicated, periodic blood counts and liver function tests should be carried out. .
Removal of propylene glycol and correction of increased osmolar . dialysis therapy. A critically ill. woman receiving high dose intrave-. nous lorazepam therapy is described. Although propylene glycol toxicity .
Lorazepam Lee DS, Wong HA, and Knoppert DC, "Myoclonus Associated With Lorazepam Therapy in Very-Low-Birth-Weight Infants," Biol Neonate , 1994, 66(6):311-5. .
Diabetic Superior Branch Palsy of the Oculomotor Nerve Lorazepam . lorazepam therapy was three minutes. The drug was effec-. tive in eight of the nine patients, producing cessation. of. seizures for more than 12 hours. .
JSTOR: Nurses' Drug Alert Two weeks after lorazepam therapy was started, orofacial dyskinesias developed. These included continuous chewing motions, repeated tongue-darting, .
Lorazepam (PIM 223) Sandyk R (1986) Orofacial diskynesias associated with lorazepam therapy. Clin Pharm, 5: 419-21. Shader RI & Dimascio A (1970) Psychotropic drug side effects .
Pharmacology Review: Drug Therapy for Neonatal Seizures: Part 1 . Myoclonus associated with lorazepam therapy in very-low-birth-weight infants. Biol Neonate. 1994;66 :311 –315[Medline]. 50. Committee on Fetus and Newborn, .
Lorazepam - News at USF Lorazepam glucuronide. Once the shaking or hallucinations. Lorazepam therapy in Very-Low-Birth-Weight as treating alcohol withdrawal insomnia and seizures! .
E S E A R C H E P R T S with both cumulative lorazepam dose and. duration of lorazepam therapy (r=0.43 and 0.60,. respectively). As shown in Table 4, all patients had .
General Hospital Psychiatry : Pregnancy and malignant catatonia . ECT was started with no immediate response; thus, 6 h later, lorazepam therapy (1 mg tid) was begun. Dramatic improvements in the agitation, rigidity, .
Calendar - Department of Natural Resources Manno EM new management of overdosage of benzodiazepines including lorazepam therapy in. The problem among many of the possibility of abuse. .
PedsCCM.org: The Pediatric Critical Care Medicine Website Dec 14, 2007 . One patient required lorazepam therapy after narcotic therapy and 1 patient responded to a dose of methadone study drug that was a placebo. .
Suppression of Pentylenetetrazol-Elicited Seizure Activity by . Lorazepam therapy of status epilep-. ticus in children and adolescents. J Pediutr 1986;108:771-4. Lathers CM, Schraeder PL. .
Myoclonus associated with lorazepam therapy in very-low-birth . Myoclonus associated with lorazepam therapy in very-low-birth-weight infants. DSC LEE, HA WONG, DC KNOPPERT Biology of the neonate 66:66, 311-315, Karger, .
Journal of Psychopharmacology dantrolene, bromocriptine and low-dose lorazepam therapy was. instigated. She had been unable to take psychotropic medication .
Propylene Glycol-Associated Renal Toxicity In our institution, lorazepam is the sedative of choice for critically ill patients . of serum creatinine concentration and duration of lorazepam therapy. .
